Approval Year
| Substance Class |
Concept
|
| Record UNII |
BCB1002X86
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C176434
Created by
admin on Wed Apr 02 06:43:58 GMT 2025 , Edited by admin on Wed Apr 02 06:43:58 GMT 2025
|
PRIMARY | |||
|
BCB1002X86
Created by
admin on Wed Apr 02 06:43:58 GMT 2025 , Edited by admin on Wed Apr 02 06:43:58 GMT 2025
|
PRIMARY | |||
|
132203319
Created by
admin on Wed Apr 02 06:43:58 GMT 2025 , Edited by admin on Wed Apr 02 06:43:58 GMT 2025
|
PRIMARY | |||
|
2166023-31-8
Created by
admin on Wed Apr 02 06:43:58 GMT 2025 , Edited by admin on Wed Apr 02 06:43:58 GMT 2025
|
PRIMARY |
This is a non-substance concept
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> INHIBITOR |
RNR activity was determined by its ability to reduce cytidine diphosphate (CDP) to deoxycytidine diphosphate (dCDP), based on a previous report
IC50
|
||
|
|
TARGET -> INHIBITOR |
Targets protein-protein interaction between R1 and R2.
Kd
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
This is a non-substance concept